Abstract:It has been a great challenge to simultaneously inhibit the outgrowth of both the primary tumor and metastasis in metastatic cancer treatment. Substantial studies have evidenced that the interaction of platelets and cancer cells supports tumor metastasis, and platelets are considered to have metastasis-targeting property. Inspired by injury-targeting and metastasis-targeting properties of platelets, we constructed a photothermal therapy strategy with activated platelet-targeting albumin-based nanoparticles, PSN-HSA-PTX-IR780, to amplify drug delivery in the primary tumor at mild temperatures and simultaneously inhibit metastasis via a "platelet bridge". Human serum albumin (HSA) was premodified with a P-selectin-targeting peptide (PSN peptide) or IR780 serving as a photosensitizer. Hybrid albumin nanoparticles were assembled via the disulfide reprogramming method and encapsulated paclitaxel (PTX) to formulate PSN-HSA-PTX-IR780. The PSN-modified albumin nanoparticles could bind with upregulated P-selectin on activated platelets and subsequently target cancer cells by using platelets as a "bridge". In addition, nanoparticle-generated hyperthermia induced tissue injury and increased tumor-infiltrating platelets, thereby recruiting more nanoparticles into the tumor in a self-promoted way. In vivo studies showed that the drug accumulation of PSN-HSA-PTX-IR780 was 2.86-fold higher than that of HSA-PTX-IR780 at the optimal temperature (45 °C), which consequently improved the therapeutic outcome. Moreover, PSN-HSA-PTX-IR780 also effectively targets and inhibits lung metastasis by binding with metastasis-infiltrating platelets. Altogether, the self-promoted nanoplatform provides a unique and promising strategy for metastatic cancer treatment with enhanced drug delivery efficacy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c04442?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c04442</a>.Synthesis route and 1H-NMR spectra of IR780SCOOH; 13C-NMR spectra and mass spectra; UV–vis–NIR absorbance and fluorescence emission spectra and temperature change curves of IR780 and IR780SCOOH; MALDI-TOF-MS spectra of HSA-IR780 and PSN-HSA; circular dichroism spectra; PTX release profiles; SEM images; cellular uptake of 4T1 cells; pharmacokinetic profiles; H&E staining images; hematology and blood biochemistry analysis (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c04442/suppl_file/am1c04442_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

An alternative and injectable preformed albumin-bound anticancer drug delivery system for anticancer and antimetastasis treatment.

Drug-binding albumins forming stabilized nanoparticles for efficient anticancer therapy.

Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models

A Biomimetic Solution, Albumin-Doxorubicin Molecular Complex, Targeting Tumor and Tumor-Draining Lymph Nodes

Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers.

Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles

Tumor Targeting Chemo- and Photodynamic Therapy Packaged in Albumin for Enhanced Anti-Tumor Efficacy

A novel nanoparticle drug delivery system based on PEGylated hemoglobin for cancer therapy

Theranostics System Caged in Human Serum Albumin As a Therapy for Breast Tumors.

Endogenous Albumin-Mediated Delivery of Redox-Responsive Paclitaxel-Loaded Micelles for Targeted Cancer Therapy

Biomimetic Shells Endow Sub-50 Nm Nanoparticles with Ultrahigh Paclitaxel Payloads for Specific and Robust Chemotherapy

Improved Anti-Tumor Activity and Safety Profile of a Paclitaxel-Loaded Glycyrrhetinic Acid-Graft-hyaluronic Acid Conjugate As a Synergistically Targeted Drug Delivery System

Co-Delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers

Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced “Platelet Bridge”

Novel Self-Assembly Endows Human Serum Albumin Nanoparticles with an Enhanced Antitumor Efficacy

Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy

Injectable, Adhesive Albumin Nanoparticle-Incorporated Hydrogel for Sustained Localized Drug Delivery and Efficient Tumor Treatment

Human Albumin Fragments Nanoparticles As PTX Carrier for Improved Anti-cancer Efficacy.

Lipoprotein-mimicking nanotherapeutics reconstituted with chenodeoxycholic acid modified protein for efficient tumor?targeting

Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment

An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy